These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32446383)

  • 1. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.
    Wu X; Xiang H; Cong W; Yang H; Zhang G; Wang Y; Guo Z; Shen Y; Chen B
    Biochem Biophys Res Commun; 2020 Jun; 527(1):29-36. PubMed ID: 32446383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
    J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
    Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
    [No Abstract]   [Full Text] [Related]  

  • 5. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
    Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
    Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
    Xu M; Jin H; Xu CX; Bi WZ; Wang Y
    Med Oncol; 2014 Jun; 31(6):972. PubMed ID: 24802328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells.
    Wang Y; Wang X; Tang J; Su X; Miao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3559-3568. PubMed ID: 31446795
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
    Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
    Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
    Wang L; Hu K; Chao Y; Wang X
    J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis.
    Trang NTN; Lai CY; Tsai HC; Huang YL; Liu SC; Tsai CH; Fong YC; Tzeng HE; Tang CH
    Int J Biol Sci; 2023; 19(2):412-425. PubMed ID: 36632453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
    Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
    Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
    Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
    Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.
    Zhang ML; Sun WH; Wu HQ; Liu ZD; Wang P
    Neoplasma; 2020 Nov; 67(6):1266-1278. PubMed ID: 32749848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
    Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
    Li Y; Liu J; Liu ZZ; Wei WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.